Article

Active surveillance an evolving approach for low-risk prostate cancer

In this interview, Laurence Klotz, MD, discusses his group's active surveillance protocol for men with favorable-risk prostate cancer, which men are candidates, how they are monitored, and triggers for active treatment.

Related Videos
Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
4 experts in this video
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.